Trial
NCT00575978
Hydralazine as Demethylating Agent in Breast Cancer
Phase IWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
University of Arkansas
Collaborators
—
Condition
Breast Cancer
Intervention
Hydralazine
Why stopped
IRB request
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-04